Financial News

Crinetics Pharmaceuticals Inc (NQ: CRNX )

56.06 -0.97 (-1.70%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 22, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Crinetics Pharmaceuticals Inc

< Previous 1 2 3 4 5 6 Next >

The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck

August 19, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 18) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business

August 17, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16) Bio-Rad Laboratories, Inc...

Via Benzinga

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight

August 08, 2021

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...

Via Benzinga

Exposures Product Safety

78 Biggest Movers From Friday

August 16, 2021

Gainers PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares jumped 43.4% to close at $3.27. PharmaCyte Biotech recently reported closing of $15-million public offering. Flora Growth...

Via Benzinga

Crinetics' Single Ascending Dose Data Shows Proof Of ACTH Antagonism In Healthy Volunteers

August 11, 2021

Crinetics Pharmaceuticals Inc (NASDAQ: CRNX) announced preliminary findings from the single ascending dose (SAD) portion of Phase 1 study evaluating CRN04894 for...

Via Benzinga

66 Biggest Movers From Yesterday

August 12, 2021

Gainers Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) shares jumped 50.5% to close at $20.74 on Wednesday. The company, last month, priced its IPO at $11 per share. Dyadic...

Via Benzinga

Topics Initial Public Offering

Exposures Securities Market

Benzinga's Top Ratings Upgrades, Downgrades For June 18, 2021

June 18, 2021

Upgrades According to JP Morgan, the prior rating for Orion Engineered Carbons SA (NYSE:

Via Benzinga

The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering

August 11, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10) Alnylam Pharmaceuticals,...

Via Benzinga

Exposures Product Safety

The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs

August 01, 2021

Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results....

Via Benzinga

Exposures Product Safety

58 Biggest Movers From Friday

June 21, 2021

Gainers CAI International, Inc. (NYSE: CAI) shares surged 46.9% to close at $56.05 on Friday after the company agreed to a $1.1 billion takeover by Mitsubishi HC Capital Inc....

Via Benzinga

32 Stocks Moving In Friday's Mid-Day Session

June 18, 2021

Gainers CAI International, Inc. (NYSE: CAI) shares jumped 46.4% to $55.86 after the company agreed to a $1.1 billion takeover by Mitsubishi HC Capital Inc. Sykes Enterprises,...

Via Benzinga

The Past Week's Notable Insider Buys Included Biotechs, Public Offerings, A SPAC And More

April 10, 2021

Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. Once again, some insiders were taking advantage of recent...

Via Benzinga

Insider Buys Crinetics Pharmaceuticals Shares

April 09, 2021

A Form 4 filing filed with the SEC on Friday, April 9 showed that Perceptive Advisors Llc bought 304,136 shares of Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) at an average...

Via Benzinga

Topics Regulatory Compliance

Exposures Legal Regulatory

12 Health Care Stocks Moving In Thursday's Intraday Session

April 08, 2021

Gainers 180 Life Sciences (NASDAQ:ATNF) stock increased by 21.18% to $9.61 during Thursday's regular session. Trading volume for this security as of 12:32 EST is 9.2...

Via Benzinga

The Daily Biotech Pulse: Immutep Extends Run, FDA Nod For Gilead, Merck, Bristol-Myers Squibb Release Late-Stage Cancer Immunotherapy Data

April 08, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 7) Aclaris Therapeutics, Inc...

Via Benzinga

Exposures Product Safety

< Previous 1 2 3 4 5 6 Next >

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Financial News

Crinetics Pharmaceuticals Inc (NQ: CRNX )

All News about Crinetics Pharmaceuticals Inc

Popular Pages